SciELO - Scientific Electronic Library Online

vol.33 número5Factores pronósticos del carcinoma de células renalesTratamiento quirúrgico de las metástasis del cáncer renal índice de autoresíndice de materiabúsqueda de artículos
Home Pagelista alfabética de revistas  

Servicios Personalizados




Links relacionados

  • En proceso de indezaciónCitado por Google
  • No hay articulos similaresSimilares en SciELO
  • En proceso de indezaciónSimilares en Google


Actas Urológicas Españolas

versión impresa ISSN 0210-4806


LLARENA IBARGUREN, Roberto. Treatment of metastatic renal cancer: current validity of immunotherapy. Actas Urol Esp [online]. 2009, vol.33, n.5, pp.584-592. ISSN 0210-4806.

Objective:To assess the significance and effects of conventional immunotherapy for management of disseminated renal cancer. Materials and methods: Historical data from studies conducted with cytokines, interferon, and interleukin are reviewed, their combinations are evaluated, and the different relevant studies available are compared. Discussion: While diverse, results are poor in terms of objective response and its duration. Historical series using interleukin-2 achieved, despite severe side effects, disease remissions, some of them complete. Conclusions: Currently, after the advent of new drugs, use of conventional immunotherapy may be indicated for specific patients with a good general condition undergoing previous nephrectomy for a clear cell carcinoma at least 12 months before occurrence of metastasis in a single organ, preferably the lung, and with normal levels of hemoglobin, calcium, and lactate dehydrogenase, looking for that small percentage of stable and sustained responses.

Palabras clave : Immunotherapy; Cytokines; Interferon; Interleukin.

        · resumen en Español     · texto en Español     · Español ( pdf )


Creative Commons License Todo el contenido de esta revista, excepto dónde está identificado, está bajo una Licencia Creative Commons